33 Recruiting Advanced Solid Tumors Phase 2 Clinical Trials
Active phase 2 studies for advanced solid tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced Solid Tumors studiesPhase 2 Studies for Advanced Solid Tumors
A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer
📍 University of California Irvine Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
📍 Local Institution - 0021 — Los Angeles, California
View Study & Checklist ➔A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
📍 Arizona Clinical Research Center, Inc.;Hematology Oncology Physicians - Aoa — Tucson, Arizona
View Study & Checklist ➔A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
📍 Valkyrie Clinical Trials — Los Angeles, California
View Study & Checklist ➔A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Clinical Study of YL205 in Patients With Advanced Solid Tumors
📍 Sarah Cannon Research Institute (SCRI)- Denver — Denver, Colorado
View Study & Checklist ➔A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
📍 Research Site 111 — Tucson, Arizona
View Study & Checklist ➔A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
📍 Sarah Cannon Research Institute at HealthOne — Denver, Colorado
View Study & Checklist ➔A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
📍 Gabrail Cancer Center — Ohio City, Ohio
View Study & Checklist ➔A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
📍 Florida Cancer Specialists - Fort Myers — Fort Myers, Florida
View Study & Checklist ➔A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
📍 Local Institution - 0007 — Los Angeles, California
View Study & Checklist ➔A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
📍 UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
📍 The University of Alabama at Birmingham ( Site 1005) — Birmingham, Alabama
View Study & Checklist ➔A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
📍 University of California, Irvine (UCI) Health - UC Irvine Medical Center — Irvine, California
View Study & Checklist ➔A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
📍 START Los Angeles, LLC — Los Angeles, California
View Study & Checklist ➔Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
📍 Hoag Memorial Hospital Presbyterian — Newport Beach, California
View Study & Checklist ➔A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation
📍 Next Oncology — San Antonio, Texas
View Study & Checklist ➔JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
📍 Morristown Medical Center — Morristown, New Jersey
View Study & Checklist ➔Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
📍 Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida
View Study & Checklist ➔First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
📍 UC Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔SNV4818 in Participants With Advanced Solid Tumors
📍 The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors
📍 Mass General Hospital — Boston, Massachusetts
View Study & Checklist ➔Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
📍 University of California San Diego — San Diego, California
View Study & Checklist ➔To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
📍 Cancer Care of North Florida, PA (Lake City Cancer Care, LLC) - Medical Oncology — Lake City, Florida
View Study & Checklist ➔